JPRN-UMIN000035991尚未招募4 期
To compare safety and efficacy of cyclosporine 0.05% and cyclosporine 0.09% eyedrops for dry eye (keratoconjunctivitis). - Cyclosporine 0.05% versus 0.09% for dry eye.
aser Eye Clinic Noida0 个研究点目标入组 40 人开始时间: 2019年2月24日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with current ocular infection, history of laser in situ keratomileusis, allergic conjunctivitis, herpetic eye disease, diabetes, and liver diseases were excluded. Other exclusion criteria were pregnant or lactating mothers, HIV, and hepatitis B and C. Patients who were allergic to fluorescein were excluded. Systemic (tetracyclines and corticosteroids) or topical medications (other than artificial tear supplements) that could affect tear production or meibomian gland functions were discontinued before intervention. However, patients were instructed not to use artificial tear preparations, 2 hours before testing. Computer work was not allowed during the course of the study as concurrent use of visual display terminals may independently influence ocular surface changes.
研究者
相似试验
已完成
不适用
The clinical effects and safty of cyclosporine with rootine corticosteroid treatment in onset MCNSminimal change nephrotic syndromeJPRN-UMIN000004653Yokohama city university graduate school of medicine20
已完成
3 期
ano-Tacrolimus and Cyclosporine effect in dry eyeIRCT20181006041253N1Birjand University of Medical Sciences24
招募中
4 期
Role of oral methotrexate, cyclosporine and acitretin in treatment of palmoplantar psoriasis (red coloured, painful, itchy, fissured lesions on hands and feet) and psoriasis vulgaris (red coloured, scaly, itchy, elevated lesions on skin over body)CTRI/2015/05/005830Krishna Institute of Medical Sciences Deemed University120
撤回
3 期
A Phase III Study Comparing Low Dose Cyclosporine, Methotrexate And Prednisone Versus Standard Dose Cyclosporine and Methotrexate As Graft Versus Host Disease Prophylaxis In Myeloblative Allogeneic Stem Cell Transplantation (ALLG BM10 trial).(Incorporating an Open-Label Sub-study Investigating The Use Of Valganciclovir In The Prevention Of Cytomegalovirus Infection In Hematopoietic Stem Cell Transplant Recipients (ML20712))ACTRN12607000347460Australasian Leukaemia and Lymphoma Group300
已完成
不适用
Efficacy and safety of cyclosporine and steroid for the treatment of minimal change nephrotic syndromeMinimal change nephrotic syndromeJPRN-UMIN000000963Yoshihiko Saito30